SENORES PHARMACEUTICALS L (SENORES) — Financial Flexibility Index
SENORES PHARMACEUTICALS L (SENORES) has a Financial Flexibility Index of 0.27x as of September 2025. Free cash flow of Rs1.21 Billion (operating CF Rs242.20 Million minus capex Rs966.90 Million) represents 0% of total liabilities (Rs4.54 Billion). Check SENORES total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
SENORES PHARMACEUTICALS L Financial Flexibility Index (2022–2026)
Historical Financial Flexibility Index trend for SENORES PHARMACEUTICALS L across 5 annual periods. For the full cash flow conversion analysis, see SENORES cash flow conversion.
Annual Financial Flexibility Index for SENORES PHARMACEUTICALS L (2022–2026)
Year-by-year free cash flow to debt coverage for SENORES PHARMACEUTICALS L. Explore SENORES cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.51x | Rs3.27 Billion | Rs620.50 Million | Rs6.39 Billion | ▼ -97.7% |
| 2025 | 22.01x | Rs1.12 Billion | Rs-459.20 Million | Rs50.70 Million | ▲ +32767.4% |
| 2024 | 0.07x | Rs261.30 Million | Rs-257.00 Million | Rs3.90 Billion | ▼ -87.6% |
| 2023 | 0.54x | Rs461.98 Million | Rs-10.79 Million | Rs855.54 Million | ▲ +5084.3% |
| 2022 | 0.01x | Rs2.35 Million | Rs-104.47 Million | Rs225.62 Million | — |